| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 0.0006 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0007 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.61 | 0.0009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.24 | 0.0009 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.63 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.001 |